125 related articles for article (PubMed ID: 38598900)
1. Human epididymis protein 4: Analysis of national health and nutrition examination survey data.
Penick ER; Beltran TA; Choi YS; Wilson KL
Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():86-90. PubMed ID: 38598900
[TBL] [Abstract][Full Text] [Related]
2. Age and menopausal status are important factors influencing the serum human epididymis secretory protein 4 level: a prospective cross-sectional study in healthy Chinese people.
Cheng HY; Zeng L; Ye X; Ma RQ; Tang ZJ; Chu HL; Zhao YM; Zhu LR; Gao YN; Chang XH; Cui H
Chin Med J (Engl); 2020 Jun; 133(11):1285-1291. PubMed ID: 32404690
[TBL] [Abstract][Full Text] [Related]
3. Determination of the Upper Reference Limit of Human Epididymis Secretory Protein 4 (HE4) in Healthy Male Individuals and Correlation with Renal and Fertility Markers.
Schirinzi A; Cazzolla AP; Mascolo E; Palmieri G; Pesce F; Gesualdo L; Santacroce L; Ballini A; Lovero R; Di Serio F
Endocr Metab Immune Disord Drug Targets; 2021; 21(5):912-918. PubMed ID: 32767951
[TBL] [Abstract][Full Text] [Related]
4. Determination of reference intervals of serum levels of human epididymis protein 4 (HE4) in Chinese women.
Tian Y; Wang C; Cheng L; Zhang A; Liu W; Guo L; Ye H; Huang Y; Chen J; Wen X; Xing Y; Zheng G; Sun Z; Li H; Zhang P; Liu W; Chen Y; Zhang Z; Xu Y; Huo Y; Ou Q
J Ovarian Res; 2015 Nov; 8():72. PubMed ID: 26552478
[TBL] [Abstract][Full Text] [Related]
5. Human Epididymis Protein 4 (HE4) Reference Limits in Polish Population of Healthy Women, Pregnant Women, and Women with Benign Ovarian Tumors.
Gasiorowska E; Kluz T; Lipski D; Warchoł W; Tykarski A; Nowak-Markwitz E
Dis Markers; 2019; 2019():3890906. PubMed ID: 31583027
[TBL] [Abstract][Full Text] [Related]
6. Comparison of HE4 and CA125 levels in women with benign gynecologic disorders : Does age or menopausal status matter?
Delić R; Štefanović M; Krivec Š; Weber V; Koren J
Wien Klin Wochenschr; 2016 Dec; 128(Suppl 7):543-547. PubMed ID: 27752776
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the predictive performance of risk of malignancy indexes 1-4, HE4 and risk of malignancy algorithm in the triage of adnexal masses.
Hada A; Han LP; Chen Y; Hu QH; Yuan Y; Liu L
J Ovarian Res; 2020 Apr; 13(1):46. PubMed ID: 32334618
[TBL] [Abstract][Full Text] [Related]
8. Epidemiologic and biologic correlates of serum HE4 and CA125 in women from the National Health and Nutritional Survey (NHANES).
Cramer DW; Vitonis AF; Sasamoto N; Yamamoto H; Fichorova RN
Gynecol Oncol; 2021 Apr; 161(1):282-290. PubMed ID: 33504456
[TBL] [Abstract][Full Text] [Related]
9. Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses.
Gentry-Maharaj A; Burnell M; Dilley J; Ryan A; Karpinskyj C; Gunu R; Mallett S; Deeks J; Campbell S; Jacobs I; Sundar S; Menon U
Am J Obstet Gynecol; 2020 Jan; 222(1):56.e1-56.e17. PubMed ID: 31351062
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of human epididymis protein 4 as a novel biomarker in patients with renal dysfunction.
Wang L; Sun Y; Cai X; Fu G
Int Urol Nephrol; 2018 Nov; 50(11):2043-2048. PubMed ID: 30006786
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age.
Moore RG; Miller MC; Eklund EE; Lu KH; Bast RC; Lambert-Messerlian G
Am J Obstet Gynecol; 2012 Apr; 206(4):349.e1-7. PubMed ID: 22301440
[TBL] [Abstract][Full Text] [Related]
12. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
Zhang M; Zhao B; Xie J; Liang Y; Yang Z
Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
[TBL] [Abstract][Full Text] [Related]
13. Consideration should be given to smoking, endometriosis, renal function (eGFR) and age when interpreting CA125 and HE4 in ovarian tumor diagnostics.
Lycke M; Ulfenborg B; Malchau Lauesgaard J; Kristjansdottir B; Sundfeldt K
Clin Chem Lab Med; 2021 Nov; 59(12):1954-1962. PubMed ID: 34388324
[TBL] [Abstract][Full Text] [Related]
14. The differential diagnostic value and clinical significance of serum HE4 in ovarian disease with elevated CA125.
Li W; Wang D
Arch Gynecol Obstet; 2020 May; 301(5):1219-1225. PubMed ID: 32266526
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performances of CA125, HE4, and ROMA index in ovarian cancer.
Dikmen ZG; Colak A; Dogan P; Tuncer S; Akbiyik F
Eur J Gynaecol Oncol; 2015; 36(4):457-62. PubMed ID: 26390703
[TBL] [Abstract][Full Text] [Related]
16. Elevated Serum Human Epididymis Protein 4 Is Associated With Disease Activity and Systemic Involvements in Primary Sjögren's Syndrome.
Chen J; Sun F; Bao H; Liang L; Zhan M; Yao H; He J; Liu Y
Front Immunol; 2021; 12():670642. PubMed ID: 34248951
[TBL] [Abstract][Full Text] [Related]
17. The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4.
Han KH; Park NH; Kim JJ; Kim S; Kim HS; Lee M; Song YS
J Gynecol Oncol; 2019 Nov; 30(6):e83. PubMed ID: 31576682
[TBL] [Abstract][Full Text] [Related]
18. HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients.
Braicu EI; Krause CL; Torsten U; Mecke H; Richter R; Hellmeyer L; Lanowska M; Müller B; Koch E; Boenneß-Zaloum J; Ames K; Chekerov R; Hasenbein K; Zimmermann M; Mangler M; Chen F; Tauber R; Sehouli J
BMC Cancer; 2022 Jul; 22(1):831. PubMed ID: 35907794
[TBL] [Abstract][Full Text] [Related]
19. Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders.
Moore RG; Miller MC; Steinhoff MM; Skates SJ; Lu KH; Lambert-Messerlian G; Bast RC
Am J Obstet Gynecol; 2012 Apr; 206(4):351.e1-8. PubMed ID: 22284961
[TBL] [Abstract][Full Text] [Related]
20. Serum human epididymis protein 4 can be a useful tumor marker in the differential diagnosis of adnexal masses during pregnancy: a pilot study.
Gucer F; Kiran G; Canaz E; Kilinc M; Ekerbicer HC; Avci F; Kiran H; Coskun A; Arikan DC
Eur J Gynaecol Oncol; 2015; 36(4):406-9. PubMed ID: 26390692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
